David S. Schrump
M.D., M.B.A
National Cancer Institute
USA
Biography
As Surgical Chief, Dr. Schrump oversees clinical and translational research pertaining to thoracic and gastrointestinal malignancies, including the development of innovative molecular approaches to the diagnosis and treatment of these neoplasms. He has pioneered the development of epigenomic therapies for thoracic cancers. Using unique in-vitro models and correlative experiments with surgical specimens, he has characterized epigenetic responses to tobacco carcinogens, and identified novel therapeutic targets in lung and esophageal cancers and pleural mesotheliomas. His clinical protocols have demonstrated that chromatin remodeling agents simultaneously induce growth arrest and augment immunogenicity of thoracic malignancies; these efforts have provided rationale for combining epigenetic regimens with immunotherapies for these neoplasms.
Research Interest
1) thoracic surgery, 2) cancer epigenetics, 3) microRNA, 4) lung cancer, 5) esophageal cancer, 6) malignant pleural mesothelioma